These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32858226)

  • 1. SARS-CoV-2 another kind of liver aggressor, how does it do that?
    Lozano-Sepulveda SA; Galan-Huerta K; Martínez-Acuña N; Arellanos-Soto D; Rivas-Estilla AM
    Ann Hepatol; 2020; 19(6):592-596. PubMed ID: 32858226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and the liver: What do we know after six months of the pandemic?
    Fierro NA
    Ann Hepatol; 2020; 19(6):590-591. PubMed ID: 32956871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and the liver: little cause for concern.
    Bangash MN; Patel J; Parekh D
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):529-530. PubMed ID: 32203680
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
    Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
    World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: COVID-19 and liver disease-what we know on 1st May 2020.
    Garrido I; Liberal R; Macedo G
    Aliment Pharmacol Ther; 2020 Jul; 52(2):267-275. PubMed ID: 32402090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):217-221. PubMed ID: 32306655
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical insight into the involvement of gut and liver by COVID-19.
    Abbas Z; Zaheer R
    J Pak Med Assoc; 2020 Jun; 70(6):952-953. PubMed ID: 32810083
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.
    Cha MH; Regueiro M; Sandhu DS
    World J Gastroenterol; 2020 May; 26(19):2323-2332. PubMed ID: 32476796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver diseases in COVID-19: Etiology, treatment and prognosis.
    Wu J; Song S; Cao HC; Li LJ
    World J Gastroenterol; 2020 May; 26(19):2286-2293. PubMed ID: 32476793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal and liver involvement in patients with COVID-19.
    Barrera FJ; González-González JG; Rodríguez-Gutiérrez R
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):799. PubMed ID: 32818458
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic consequences of COVID-19 infection. Lapping or biting?
    Portincasa P; Krawczyk M; Machill A; Lammert F; Di Ciaula A
    Eur J Intern Med; 2020 Jul; 77():18-24. PubMed ID: 32507608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liver in times of COVID-19: What hepatologists should know.
    Ridruejo E; Soza A
    Ann Hepatol; 2020; 19(4):353-358. PubMed ID: 32425991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological manifestations and comorbidity associated with COVID-19: an overview.
    Kumar M; Thakur AK
    Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal and liver manifestations of COVID-19.
    Cheong J; Bartell N; Peeraphatdit T; Mosli M; Al-Judaibi B
    Saudi J Gastroenterol; 2020; 26(5):226-232. PubMed ID: 32367837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 pandemic: Its impact on liver disease and liver transplantation.
    Sahin TT; Akbulut S; Yilmaz S
    World J Gastroenterol; 2020 Jun; 26(22):2987-2999. PubMed ID: 32587443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maculopapular rash as initial manifestation of SRAS-coronavirus-2 infection.
    Falkenhain López D; Sánchez-Velázquez A; Ortiz de Frutos J
    Med Clin (Barc); 2020 Jul; 155(2):92. PubMed ID: 32402389
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
    Iroegbu JD; Ifenatuoha CW; Ijomone OM
    Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study.
    Rigamonti C; Cittone MG; De Benedittis C; Rizzi E; Casciaro GF; Bellan M; Sainaghi PP; Pirisi M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2369-2371.e1. PubMed ID: 32480009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Qiu H; Wander P; Bernstein D; Satapathy SK
    Liver Int; 2020 Jul; 40(7):1590-1593. PubMed ID: 32369658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.